These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 37166347)

  • 1. Impact of immunosuppressive regimen on ICU acquired pneumonia in critically ill COVID-19.
    Villa A; Bougouin W; Urbina T; Bonny V; Gabarre P; Missri L; Baudel JL; Buzzi JC; Guidet B; Ait-Oufella H; Maury E; Joffre J
    Minerva Anestesiol; 2023 Sep; 89(9):783-791. PubMed ID: 37166347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired agitation in acute respiratory distress syndrome with COVID-19 compared to influenza patients: a propensity score matching observational study.
    Maamar A; Liard C; Doucet W; Reizine F; Painvin B; Delamaire F; Coirier V; Quelven Q; Guillot P; Lesouhaitier M; Tadié JM; Gacouin A
    Virol J; 2022 Sep; 19(1):145. PubMed ID: 36085163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
    Yang X; Yu Y; Xu J; Shu H; Xia J; Liu H; Wu Y; Zhang L; Yu Z; Fang M; Yu T; Wang Y; Pan S; Zou X; Yuan S; Shang Y
    Lancet Respir Med; 2020 May; 8(5):475-481. PubMed ID: 32105632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Early Tocilizumab Effect on Multiorgan Dysfunction in Critically Ill Patients With COVID-19: A Propensity Score-Matched Study.
    Aljuhani O; Korayem GB; Altebainawi AF; Al Harthi A; Badreldin HA; Alsalloum MA; Eljaaly K; Alharbi A; Aljehani R; Vishwakarma R; Alenazi AA; Alalawi M; Alissa A; Al Aamer K; Al Enazi H; Almusallam M; Alshehri A; Bukhari R; Alasmari G; AlQahtani MM; Al Shammari S; Alsulaymi HO; Al Sulaiman K
    J Intensive Care Med; 2023 Jun; 38(6):534-543. PubMed ID: 36683420
    [No Abstract]   [Full Text] [Related]  

  • 5. The Use of High-Dose Corticosteroids Versus Low-Dose Corticosteroids With and Without Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome.
    Katz A; Altshuler D; Papadopoulos J; Amoroso N; Goldenberg R; Tarras E; Krolikowski K; Hagedorn J; Fridman D; Chen XJC; Iturrate E; Brosnahan SB
    Ann Pharmacother; 2023 Jan; 57(1):5-15. PubMed ID: 35590468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: A case-series.
    Alharthy A; Faqihi F; Memish ZA; Balhamar A; Nasim N; Shahzad A; Tamim H; Alqahtani SA; Brindley PG; Karakitsos D
    Artif Organs; 2021 May; 45(5):E101-E112. PubMed ID: 33190288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.
    COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators
    Intensive Care Med; 2021 Jan; 47(1):60-73. PubMed ID: 33211135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19.
    Gupta S; Wang W; Hayek SS; Chan L; Mathews KS; Melamed ML; Brenner SK; Leonberg-Yoo A; Schenck EJ; Radbel J; Reiser J; Bansal A; Srivastava A; Zhou Y; Finkel D; Green A; Mallappallil M; Faugno AJ; Zhang J; Velez JCQ; Shaefi S; Parikh CR; Charytan DM; Athavale AM; Friedman AN; Redfern RE; Short SAP; Correa S; Pokharel KK; Admon AJ; Donnelly JP; Gershengorn HB; Douin DJ; Semler MW; Hernán MA; Leaf DE;
    JAMA Intern Med; 2021 Jan; 181(1):41-51. PubMed ID: 33080002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Dose Steroids for Nonresolving Acute Respiratory Distress Syndrome in Critically Ill COVID-19 Patients Treated With Dexamethasone: A Multicenter Cohort Study.
    Lopinto J; Arrestier R; Peiffer B; Gaillet A; Voiriot G; Urbina T; Luyt CE; Bellaïche R; Pham T; Ait-Hamou Z; Roux D; Clere-Jehl R; Azoulay E; Gaudry S; Mayaux J; Mekontso Dessap A; Canoui-Poitrine F; de Prost N
    Crit Care Med; 2023 Oct; 51(10):1306-1317. PubMed ID: 37199534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.
    Al Sulaiman K; Korayem GB; Altebainawi AF; Al Harbi S; Alissa A; Alharthi A; Kensara R; Alfahed A; Vishwakarma R; Al Haji H; Almohaimid N; Al Zumai O; Alrubayan F; Asiri A; Alkahtani N; Alolayan A; Alsohimi S; Melibari N; Almagthali A; Aljahdali S; Alenazi AA; Alsaeedi AS; Al Ghamdi G; Al Faris O; Alqahtani J; Al Qahtani J; Alshammari KA; Alshammari KI; Aljuhani O
    Crit Care; 2022 Oct; 26(1):304. PubMed ID: 36192801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocilizumab Associated With Survival in Patients Hospitalized for COVID-19 Acute Respiratory Distress Syndrome and Low Urine Output.
    Fadel RA; Scott A; Parsons A; Murskyj I; Nasiri N; Abu Sayf A; Ouellette D
    J Intensive Care Med; 2023 Nov; 38(11):1042-1050. PubMed ID: 37306148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
    Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
    Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Kidney Injury in Critical Care COVID-19 Patients on Invasive Mechanical Ventilation: The Potential Preventive Role of Dexamethasone.
    Mejia-Vilet JM; Del Toro-Cisneros N; Caballero-Islas AE; Martínez-Rueda AJ; Hernández-Flores J; Proaño-Zamudio JA; Sacoto-Romo VM; Fernández-Camargo DA; Comunidad-Bonilla RA; Navarro-Gerrard MA; Correa-Rotter JR; Vega-Vega O
    Rev Invest Clin; 2022; 75(2):76-89. PubMed ID: 37205793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients.
    Cala-García JD; Sierra-Bretón JD; Cavelier-Baiz JE; Faccini-Martínez ÁA; Pérez-Díaz CE
    Immunotherapy; 2020 Oct; 12(15):1127-1132. PubMed ID: 32664810
    [No Abstract]   [Full Text] [Related]  

  • 15. Bloodstream infections in critically ill patients with COVID-19.
    Giacobbe DR; Battaglini D; Ball L; Brunetti I; Bruzzone B; Codda G; Crea F; De Maria A; Dentone C; Di Biagio A; Icardi G; Magnasco L; Marchese A; Mikulska M; Orsi A; Patroniti N; Robba C; Signori A; Taramasso L; Vena A; Pelosi P; Bassetti M
    Eur J Clin Invest; 2020 Oct; 50(10):e13319. PubMed ID: 32535894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between tocilizumab therapy and the development of thrombosis in critically ill patients with COVID-19: a multicenter, cohort study.
    Aljuhani O; Al Sulaiman K; Korayem GB; Altebainawi AF; Alsohimi S; Alqahtani R; Alfaifi S; Alharbi A; AlKhayrat A; Hattan A; Albassam M; Almohammed OA; Alkeraidees A; Alonazi DA; Alsalman WF; Aldamegh G; Alshahrani R; Vishwakarma R
    Sci Rep; 2024 Feb; 14(1):3037. PubMed ID: 38321099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia.
    Aomar-Millán IF; Fatoul-Del Pino G; Torres-Parejo Ú; Pérez-Fernández L; Martínez-Diz S; Salvatierra J
    Med Clin (Barc); 2023 Feb; 160(4):156-159. PubMed ID: 35987733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy.
    Popadic V; Klasnja S; Milic N; Rajovic N; Aleksic A; Milenkovic M; Crnokrak B; Balint B; Todorovic-Balint M; Mrda D; Zdravkovic D; Toskovic B; Brankovic M; Markovic O; Bjekic-Macut J; Djuran P; Memon L; Brajkovic M; Todorovic Z; Hadzi-Djokic J; Jovanovic I; Nikolic D; Zdravkovic M
    Oxid Med Cell Longev; 2021; 2021():6648199. PubMed ID: 33968298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.
    Ferrando C; Mellado-Artigas R; Gea A; Arruti E; Aldecoa C; Bordell A; Adalia R; Zattera L; Ramasco F; Monedero P; Maseda E; Martínez A; Tamayo G; Mercadal J; Muñoz G; Jacas A; Ángeles G; Castro P; Hernández-Tejero M; Fernandez J; Gómez-Rojo M; Candela Á; Ripollés J; Nieto A; Bassas E; Deiros C; Margarit A; Redondo FJ; Martín A; García N; Casas P; Morcillo C; Hernández-Sanz ML;
    Rev Esp Anestesiol Reanim (Engl Ed); 2020 Oct; 67(8):425-437. PubMed ID: 32800622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single versus multiple doses of Tocilizumab in critically ill patients with coronavirus disease 2019 (COVID-19): A two-center, retrospective cohort study.
    Al Sulaiman K; Aljuhani O; Bin Salah K; Korayem GB; Eljaaly K; Al Essa M; Kharbosh A; Al Harbi F; Abuzaid M; Al Bilal S; Almagthali A; Alsohemi S; Alshabasy A; Noureldeen H; Aboudeif M; Alshehri A; Vishwakarma R
    J Crit Care; 2021 Dec; 66():44-51. PubMed ID: 34438133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.